Wolverine Asset Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Wolverine Asset Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,194	Closed	-$348K	–	2106
2020 Q3	$348K	Buy	+19,194	New	+$272K	﹤0.01%	830

Wolverine Asset Management's AKCA Position: Q4 2020 in Review

Wolverine Asset Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 19,194 shares — an estimated $348K sold.

Wolverine Asset Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $348K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Wolverine Asset Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Wolverine Asset Management sold 19,194 Akcea Therapeutics Inc shares in Q4 2020, an estimated $348K.
Wolverine Asset Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Wolverine Asset Management's Akcea Therapeutics Inc position peaked at $348K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.